Detalhe da pesquisa
1.
Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice.
Drug Metab Dispos
; 46(9): 1304-1309, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915157
2.
NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.
Prev Chronic Dis
; 11: E220, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25523351
3.
A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.
Clin Pharmacol Ther
; 114(3): 633-643, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218407
4.
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD.
Kidney360
; 1(11): 1206-1216, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322673
5.
Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.
Sci Transl Med
; 12(548)2020 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554707
6.
ACCP Position Statement on Hydration and Vitamin Infusion Clinics.
J Clin Pharmacol
; 64(1): 10-12, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792799
7.
Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease.
J Pharm Biomed Anal
; 174: 618-624, 2019 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276982
8.
Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease.
Sci Rep
; 9(1): 15901, 2019 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685846
9.
Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis.
Clin J Am Soc Nephrol
; 14(2): 261-267, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665924
10.
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
Expert Rev Clin Pharmacol
; 11(1): 71-82, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905671
11.
Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous Catheters.
Front Med (Lausanne)
; 5: 308, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30456212
12.
Endotoxin binding by sevelamer: potential impact on nutritional status.
Int J Nephrol
; 2013: 954956, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23401772
13.
Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species.
PLoS One
; 7(11): e49209, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23166614